Business · 29/04/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Endocrinologic and Metabolic Drugs Advisory Committee for Biologics License Application
Summary
The FDA is hosting a public meeting of its Endocrinologic and Metabolic Drugs Advisory Committee to provide advice on a biologics license application for a new insulin injection, and is seeking public comments on the matter.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →